The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...

Ijeoma Uchegbu discusses nanomedicine's role in improving medication adherence and developing non-addictive pain relief ...

In addition, it can allow the buildup of a small molecule known as methylmalonic acid (MMA). In healthy tissues, vitamin B12 helps break down MMA. In B12 deficient patients, MMA is increased and can ...

Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...

SAN DIEGO, November 13, 2024--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a ...

Researchers at Case Western Reserve University have identified a new target to treat atherosclerosis, a condition where ...

A year out from Leqembi’s approval for Alzheimer’s disease (AD), ongoing research coupled with artificial intelligence is ...

Extracellular vesicles (EVs) loaded with customizable anti-cancer antisense oligonucleotides suppressed cancer growth.

The novel oral first-in-class anti-inflammatory agent has demonstrated robust efficacy and high safety margins in preclinical studies, and is the first drug candidate to advance to clinical trials ...